| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |